|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
| Filed by the Registrant /x/ |
||
| Filed by a Party other than the Registrant / / | ||
| Check the appropriate box: |
||
| /x/ | Preliminary Proxy Statement | |
| / / | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| / / | Definitive Proxy Statement | |
| / / | Definitive Additional Materials | |
| / / | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-12 |
|
| OXBORO MEDICAL INTERNATIONAL, INC. |
|
| (Name of Registrant as Specified In Its Charter) | |
| N/A |
|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| Payment of Filing Fee (Check the appropriate box): | ||||
| /x/ | No fee required | |||
| / / | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11 | |||
| (1) | Title of each class of securities to which transaction applies: |
|||
| (2) | Aggregate number of securities to which transaction applies: |
|||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|||
| (4) | Proposed maximum aggregate value of transaction: |
|||
| (5) | Total fee paid: |
|||
| / / | Fee paid previously with preliminary materials. | |||
| / / | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| (1) | Amount Previously Paid: |
|||
| (2) | Form, Schedule or Registration Statement No.: |
|||
| (3) | Filing Party: |
|||
| (4) | Date Filed: |
|||
PRELIMINARY PROXY MATERIALS
[LOGO]
February , 2000
TO OUR SHAREHOLDERS:
You are cordially invited to attend the 2000 Annual Meeting of Shareholders of Oxboro Medical International, Inc. This meeting will be held on Thursday, March , 2000, at 4:00 p.m., Central Standard Time, at the Company's offices, 13828 Lincoln Street, N.E., Ham Lake, Minnesota 55304. Details concerning the meeting are presented in the Notice of Annual Meeting and Proxy Statement which follow.
Your vote is important. We encourage you to read the Proxy Statement and sign and return your proxy card in the prepaid envelope provided, so that your shares will be represented at the meeting.
Sincerely,
/s/ Matthew E. Bellin
Matthew
E. Bellin
President
13828 Lincoln Street N.E. Ham Lake, Minnesota 55304
Oxboro Medical International, Inc.
13828 Lincoln Street N.E.
Ham Lake, Minnesota 55304
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
March , 2000
Notice is hereby given that the Annual Meeting of Shareholders of Oxboro Medical International, Inc. (the "Company") will be held at the Company's offices, 13828 Lincoln Street N.E., Ham Lake, Minnesota 55304, on Thursday, March , 2000 at 4:00 p.m., local time, for the following purposes:
The Board of Directors has fixed the close of business on January 18, 2000, as the record date for the determination of shareholders entitled to notice of and to vote at the Annual Meeting. The transfer books of the Company will not be closed.
It is important that your shares be represented and voted at the Annual Meeting and you are invited to attend. A majority of the outstanding shares of the Company's Common Stock must be represented either in person or by proxy to constitute a quorum for the conduct of business at the meeting. Accordingly, Shareholders who do not expect to be present in person at the Annual Meeting are urged to complete, date, sign and return the accompanying Proxy in the enclosed, self-addressed envelope.
By Order of the Board of Directors,
Robert S. Garin, Chairman
Ham
Lake, Minnesota
February , 2000
To ensure your representation at the Annual Meeting, please sign, date and return your proxy in the enclosed envelope, whether or not you expect to attend in person. Shareholders who attend the meeting may revoke their proxies and vote in person if they so desire. This proxy is solicited on behalf of the Board of Directors of the Company.
Oxboro Medical International, Inc.
13828 Lincoln Street N.E.
Ham Lake, Minnesota 55304
PROXY STATEMENT
The Board of Directors of Oxboro Medical International, Inc. (the "Company") is soliciting your proxy for use at the 2000 Annual Meeting of Shareholders to be held on Thursday, March , 2000 or any adjournment or adjournments thereof. This Proxy Statement and the enclosed form of proxy will be mailed to shareholders commencing on or about February , 2000.
Voting
Each share of the Company's Common Stock is entitled to one vote. You may vote your shares in person by attending the Annual Meeting or you may vote by proxy. If you vote by proxy, you must sign, date and return the enclosed proxy card in the envelope provided.
If you sign and return the proxy card on time, the individuals named on the proxy card will vote your shares as you have directed. If you do not specify on your proxy card how you want your shares voted, the individuals named on the enclosed proxy card will vote your shares FOR Proposal One—Election of one nominee for Class I director as described below, FOR Proposal Two—adoption of an amendment to the Articles of Incorporation of the Company (the "Articles") to change the name of the Company, FOR Proposal Three—adoption of an amendment to the Articles to increase the number of authorized shares, FOR Proposal Four—adoption of an amendment to the Articles to reduce supermajority voting provisions, FOR Proposal Five—adoption of an amendment to the Articles to elect not to be subject to the Minnesota Business Combination Act, FOR Proposal Six—adoption of an amendment to the Articles to elect not to be subject to the Minnesota Control Share Acquisition Statute, FOR Proposal Seven—adoption of an amendment to the Articles to permit directors of the Company to take written action by less than unanimous consent, and FOR Proposal Eight—adoption of the Company's 2000 Stock Option Plan.
Quorum and Vote Requirements
The total number of shares outstanding and entitled to vote at the meeting as of January 18, 2000 consisted of 1,338,102 shares of Common Stock, $.01 par value per share. Each share of Common Stock is entitled to one vote. Only shareholders of record at the close of business on January 18, 2000 will be entitled to vote at the meeting. A quorum, consisting of a majority of the shares of Common Stock entitled to vote at the Annual Meeting, must be present in person or by proxy before action may be taken at the Annual Meeting. If an executed proxy is returned and the shareholder has abstained from voting on any matter, the shares represented by such proxy will be considered present at the meeting for purposes of determining a quorum and for purposes of calculating the vote, but will not be considered to have been voted in favor of such matter. If an executed proxy is returned by a broker holding shares in "street name" indicating that the broker does not have discretionary authority as to certain shares to vote on one or more matters, such shares will be considered present at the meeting for purposes of determining a quorum, but will not be considered to be represented at the meeting for purposes of calculating the vote with respect to such matters.
Proposals 1, 2, 3, 7 and 8 presented at the Annual Meeting will be approved if a majority of the shares of Common Stock present in person or represented by proxy vote for the proposal. Proposals 4, 5 and 6 will be approved if 75% of the shares present in person or represented by proxy vote for the proposal. Broker nonvotes are not counted as votes for or against a proposal. Abstentions are counted in determining the total number of votes cast on a proposal. An abstention has the effect of a negative vote.
Revoking A Proxy
If you give a proxy and later wish to revoke it before it is voted, you may do so by (1) sending a written notice to that effect to the Secretary of the Company at the address indicated in this Proxy Statement, (2) submitting a properly signed proxy with a later date, or (3) voting in person at the Annual Meeting. Otherwise, your shares will be voted as indicated on your proxy.
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table shows the amount of Common Stock beneficially owned, as of January 18, 2000 by (1) shareholders known by the Company to hold more than 5% of the Common Stock of the Company, (2) each director and executive officer of the Company, and (3) all current directors and executive officers of the Company as a group. Unless otherwise indicated, the persons listed below have sole voting investment power with respect to the shares:
| Name and Address of of Beneficial Owner |
Number of Shares Beneficially Owned(1) |
Percentage Beneficially Owned |
|||
|---|---|---|---|---|---|
| Matthew E. Bellin | 44,066 | (2) | 3.2 | % | |
| 13828 Lincoln Street NE | |||||
| Ham Lake, MN 55304 | |||||
| Robert S. Garin | 9,000 | (3) | * | ||
| 17553 Eidelweiss Street NW | |||||
| Andover, Minnesota 55304 | |||||
| CMM Properties LLC | 449,285 | (4) | 30.6 | % | |
| c/o Gary W. Copperud | |||||
| 13828 Lincoln St. NE | |||||
| Ham Lake, MN 55304 | |||||
| Kenneth W. Brimmer | 256,096 | (5) | 18.1 | % | |
| 720 South Fifth Street | |||||
| Hopkins, Minnesota 55343 | |||||
| John E. Sayer | 12,800 | (6) | * | ||
| Power Process Equipment | |||||
| 7630 Commerce Way | |||||
| Eden Prairie, Minnesota 55304 | |||||
| All Current Directors and Executive | |||||
| Officers as a Group (5 persons) | 771,247 | (7) | 48.8 | % |
PROPOSAL 1: ELECTION OF DIRECTORS
Under the Company's Articles of Incorporation, as amended, the shareholders may from time to time determine the size of the Board and the Board may increase the number of Directors by affirmative vote of two thirds (2/3) of the directors. The shareholders have currently fixed the number of directors at four.
The Company's Articles of Incorporation provide that the Board of Directors is classified into three classes, the members of each class to serve (after an initial transition period) for a staggered term of three years. As the term of each class expires, the successors to the directors in that class will be elected for a term of three years. At this Annual Meeting, the term of one incumbent director, Robert S. Garin, is expiring. Mr. Garin is not seeking re-election as a director and Ms. Gervaise Wilhelm has been nominated for election to Class I and if elected will serve for a term of three years. The terms of Messrs. Kenneth W. Brimmer and Gary W. Copperud will expire at the Annual Meeting of Shareholders following fiscal year 2000 and the term of Mr. John E. Sayer will expire at the Annual Meeting of Shareholders following fiscal year 2001. Vacancies on the Board of Directors can be filled by vote of a majority of the directors then in office. Newly created directorships can be filled by vote of two-thirds of the directors then in office.
One director will be elected at the Annual Meeting to serve until the Annual Meeting of Shareholders following fiscal year 2002 or until his successor or successors are elected. The Board of Directors has nominated for election Ms. Gervaise Wilhelm to serve as a director.
It is intended that proxies will be voted for the named nominee. Unless otherwise indicated, each nominee, and each continuing director named below, has been engaged in his present occupation as set forth below, or has been an officer with the organization indicated, for more than five years. The Board of Directors believes that the nominee named below will be able to serve. However, should the nominee be unable to serve as a director, the persons named by the Company as proxies for this Annual Meeting have advised that they will vote for the election of any substitute nominee that the Board of Directors may propose.
The names and biographical information concerning the Class I nominee and the other directors filling unexpired terms are set forth below, based upon information furnished to the Company by the nominee and directors. Each nominee listed below has consented to serve if elected. If a nominee is unable to serve for any reason, the persons named on the enclosed proxy card may vote for a substitute nominee proposed by the Board. Alternatively, the shareholders may reduce the number of directors to be elected, provided that any reduction is approved by the affirmative vote of not less than 75% of the Company's shares outstanding and entitled to vote.
Nominees for Election to the Board of Directors
Nominees for Class I Director (term expires after fiscal year 2002):
Gervaise Wilhelm, age 56. Ms. Wilhelm has been a partner with Surgical Safety Associates, a manufacturer of surgical safety disposable devices, since October 1999. Since 1997, Ms. Wilhelm has also served as a consultant to start-up medical device companies, including companies operating in the medical specialty areas of urology, surgery, cardiology, gastroenterology and critical care medicine. From 1994 to 1997, Ms. Wilhelm served as president and chief executive officer of Internventional Innovations, Inc., now KRT Corp., a medical device company.
Directors serving continuing terms:
Continuing Class II Directors (term expires after fiscal year 2000):
Gary W. Copperud, age 41. Mr. Copperud has been a director of the Company since February 1998. He has been president/general manager of CMM Properties, LLC, an investment company with holdings in real estate and stocks, since 1993. Prior to that, Mr. Copperud was self-employed in the fields of securities and real estate investment and real estate development.
Kenneth W. Brimmer, age 44. Mr. Brimmer has been a director of the Company since February 1998. He has been president and secretary since 1997, a director since 1996 and treasurer since 1995 of Rainforest Cafe, Inc. From October to December 1997, Mr. Brimmer was employed by Grand Casinos, Inc. and its predecessor, as Special Assistant to the chairman and chief executive officer. Mr. Brimmer is also a director of New Horizon Kids Quest, Inc. and Hypertension Diagnostics, Inc., both publicly-held companies.
Continuing Class III Directors (term expires after fiscal year 2001):
John E. Sayer, age 51. Mr. Sayer has been a director of the Company since February 1998. He is currently Vice President and a director of Power Process Equipment, Inc., an industrial coating, pump packing, parts and mechanical seals and process controls equipment sales and service company located in Eden Prairie, Minnesota. Mr. Sayer has been an owner, officer and director of Power Process Equipment, Inc. since October 1974.
Meetings and Committees of the Board of Directors
The Board of Directors has appointed an Audit Committee and a Compensation Committee. The Audit Committee assists the Board in overseeing the Company's accounting policies, internal auditing procedures, internal controls and financial reporting practices. Its functions include making recommendations regarding the appointment and retention of the Company's independent auditors and reviewing the scope and results of audits by the independent auditors. Members of the Audit Committee are Messrs. Brimmer, Copperud and Sayer. The Compensation Committee reviews and makes recommendations to the Board concerning salaries, bonus awards and benefits for officers and key employees. Members of the Compensation Committee are Messrs. Sayer, Garin and Copperud.
The Board of Directors met eleven times and took written action in lieu of meeting four times during fiscal year 1999. The Audit Committee and the Compensation committee each met twice during fiscal year 1999. Each incumbent director attended at least 75% of the total number of Board of Directors meetings and Board committee meetings on which he served during fiscal year 1999.
Compensation of Directors
Compensation Paid to Outside Directors
Each director of the Company who is not an employee receives compensation of $1,000 per quarter for services as a director and the Chairman of the Board receives $1,250 per quarter. The aggregate fees paid to non-management directors for services rendered for the years ended September 30, 1999 and 1998 were approximately $19,000 and $32,350, respectively. On April 20, 1999, the Company granted immediately exercisable options to Kenneth W. Brimmer, John E. Sayer and Gary W. Copperud, each for purchase of 4,000 shares of Common Stock at a purchase price of $5.00 per share. The Company also granted an immediately exercisable option to Chairman of the Board Robert S. Garin for purchase of 1,000 shares of Common Stock at a purchase price of $5.00 per share. All share numbers and exercise prices reflect a 1-for-5 reverse stock split effected by the Company on August 13, 1999. Ms. Gervaise Wilhelm, a nominee for election as a director, was paid $12,000 by the Company in 1999 for business development consulting services.
Compensation Paid to Former Directors
A former director of the Company, Dennis Mikkelson, was paid approximately $18,000 and $64,000 during the fiscal years ended September 30, 1999 and 1998, respectively, for general business consulting and for development and enhancement of the Company's computer capabilities. A former director, John Walter, received approximately $10,000 in commissions from the sale of insurance policies to the Company during each of the fiscal years ended September 30, 1999 and 1998. A former director, R.J. Fritz, was paid $10,333 for his services as a director during fiscal year 1999.
Vote Required. The affirmative vote of a majority of the shares of Common Stock represented at the Annual Meeting in person or by proxy is required for the election of the nominee.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR"
THE ELECTION OF THE NOMINEE DIRECTOR
EXECUTIVE COMPENSATION AND OTHER INFORMATION
The following table sets forth the aggregate compensation for the years indicated of the Company's executive officers who earned salary and bonus in excess of $100,000.
Summary Compensation Table
The following table shows, for the fiscal years ending September 30, 1999, 1998 and 1997, the cash compensation paid by the Company, as well as certain other compensation paid or accrued to those years, to Matthew E. Bellin, the Company's President, Chief Operating Officer and interim Chief Financial Officer, Larry A. Rasmusson, the Company's former Chief Executive Officer and Chief Financial Officer, Christopher Turnbull, the Company's former interim Chief Executive Officer and to each of the four other most highly compensated executive officers of the Company in office during fiscal year 1999, whose total cash compensation exceeded $100,000 during fiscal year 1999 (together with Messrs. Bellin, Rasmusson and Turnbull, the "Named Executive Officers") in all capacities in which they served:
| |
|
|
|
Long-Term Compensation Awards |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
Annual Compensation(1) |
|
||||||||||
| Name and Principal Position |
Fiscal Year |
Securities Underlying Options (# Shares) |
All Other Compensation |
||||||||||
| Salary |
Bonus |
||||||||||||
| Matthew E. Bellin(2) | 1999 | $ | 61,539 | — | — | — | |||||||
| President, Chief Operating Officer | 1998 | — | — | — | — | ||||||||
| and interim Chief Financial Officer | 1997 | — | — | — | — | ||||||||
| Larry A. Rasmusson(3) | 1999 | — | — | — | — | ||||||||
| Former Chief Executive Officer | 1998 | 263,388 | — | $ | 93,604 | (4) | |||||||
| and Chief Financial Officer | 1997 | 262,975 | — | 92,579 | |||||||||
| Christopher Turnbull(5) | 1999 | 16,000 | — | — | — | ||||||||
| Former interim Chief | 1998 | 24,000 | — | — | — | ||||||||
| Executive Officer | 1997 | — | — | — | — | ||||||||
| Andrew Isle(6) | 1999 | 49,700 | — | — | — | ||||||||
| Former President of | 1998 | 18,859 | — | — | — | ||||||||
| Oxboro Outdoors, Inc. | 1997 | — | — | — | — | ||||||||
Option Grants
The following table provides information about each stock option grant made during the fiscal year ended September 30, 1999 to the Named Executive Officers:
| Name |
Options Granted |
% of Total Options Granted to Employees in Fiscal Year |
Exercise or Base Price Per Share |
Market Price on Date of Grant |
Expiration Date |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Matthew E. Bellin | 4,000 | 47 | % | $ | 7.50 | $ | 7.50 | 02/15/2005 | ||||
| 4,000 | 47 | % | $ | 7.50 | $ | 7.50 | 02/15/2006 | |||||
| 4,000 | 47 | % | $ | 7.50 | $ | 7.50 | 02/15/2007 | |||||
| 4,000 | 47 | % | $ | 7.50 | $ | 7.50 | 02/15/2008 | |||||
| 4,000 | 47 | % | $ | 7.50 | $ | 7.50 | 02/15/2009 | |||||
| Christopher Turnbull(1) | 200 | .04 | % | $ | 7.50 | $ | 5.00 | 10/01/2003 | ||||
| 200 | .04 | % | $ | 7.50 | $ | 8.75 | 11/01/2003 | |||||
| 200 | .04 | % | $ | 7.50 | $ | 7.80 | 12/01/2003 | |||||
| 200 | .04 | % | $ | 7.50 | $ | 5.30 | 01/01/2004 | |||||
| 200 | .04 | % | $ | 7.50 | $ | 6.40 | 02/01/2004 | |||||
Option Exercises and Year-End Values
No stock options were exercised by the Named Executive Officers during the fiscal year ended September 30, 1999. The following table sets forth certain information regarding exercised and unexercised options held by each of the Named Executive Officers at the end of the fiscal year ended September 30, 1999.
| |
Aggregated Option Exercises in Fiscal Year 1999 and Option Values at Fiscal Year End |
|
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
|
|
Number of Securities Underlying Unexercised Options at September 30, 1999 |
|
|
||||||||||
| |
|
|
Value of Unexercised In-the-Money Options at September 30, 1999(2) |
||||||||||||
| Name |
Shares Acquired On Exercise(#) |
Value Realized(1) |
|||||||||||||
| Exercisable |
Unexercisable |
Exercisable |
Unexercisable |
||||||||||||
| Matthew E. Bellin | — | $ | — | 4,000 | 16,000 | $ | — | $ | — | ||||||
Employment Agreements
On February 10, 1999, the Company entered into an employment agreement with Matthew E. Bellin to serve as its President, Chief Operating Officer and interim Chief Financial Officer. Pursuant to the employment agreement, Mr. Bellin is to be paid a minimum annual salary (exclusive of benefits, bonuses or incentive payments) of $100,000, subject to review and adjustment annually by the Board of Directors. Mr. Bellin will also be paid a discretionary cash bonus and incentive compensation equal to 20% of his annual salary, based upon mutually acceptable objectives. Payment of the bonus and incentive compensation, if any, has not yet been determined and is contingent upon the successful completion of Mr. Bellin's first year of employment with the Company. In addition, the employment agreement provides for the one-time grant of options to purchase 20,000 shares of Common Stock of the Company (100,000 shares as adjusted to reflect the Company's 1-for-5 reverse stock split effective August 13, 1999), at an exercise price of $7.50 per share (as adjusted for the reverse split), vesting with respect to 4,000 shares annually. (The Compensation Committee has not yet made any determination regarding bonus and incentive payments in 1999 with respect to Mr. Bellin or any other executive officer.) As a condition of the employment agreement, Mr. Bellin also executed an Employee Noncompetition and Confidentiality Agreement with the Company under which he agreed not to engage in activities (described in the Agreement) hostile or adverse to the Company or Oxboro Outdoors, Inc. Under the terms of the Agreement, for a period of one year after termination of the Agreement, Mr. Bellin is prohibited from engaging in activities (as described in the Agreement) that are competitive to the Company or Oxboro Outdoors or from attempting to employ any Company or Oxboro Outdoors employee or persuading such person to terminate employment with the Company or Oxboro Outdoors. Mr. Bellin's annual salary was increased to $120,000 effective October 1, 1999. Effective January 3, 2000, and subject to shareholder approval of the Oxboro Medical International, Inc. 2000 Stock Option Plan, the Company granted Mr. Bellin an option to purchase 65,000 shares of Common Stock of the Company at an exercise price of $3.50 per share. The shares vest annually with respect to 13,000 shares, for five years, beginning on the first anniversary date of Mr. Bellin's employment.
Certain Relationships and Related Transactions
Agreements with Larry A. Rasmusson
Employment Agreements. During fiscal year 1994, the Company entered into an employment agreement with Larry A. Rasmusson, former Chief Executive Officer and Chief Financial Officer, whereby he was paid an annual salary determined each fiscal year, a bonus, the amount of which was based upon achievement by the Company of certain financial goals, and other benefits. Effective September 1, 1998, the Company and Mr. Rasmusson entered into a Mutual Release & Noncompetition Agreement (the "Mutual Release & Noncompetition Agreement") that provided for the termination of Mr. Rasmusson's employment agreement in consideration of payment of $150,000 over 24 months, the amendment of his consulting agreement with the Company, the surrender of 510,000 shares of Common Stock to the Company, an amendment to an exclusive license and royalty agreement between Mr. Rasmusson and Oxboro Outdoors, Inc., the recission of the exercise of options for 220,364 shares of Common Stock of the Company, and a mutual release of claims.
License Agreements. Pursuant to an exclusive license agreement, Mr. Rasmusson, as licensor, granted the Company, as licensee, the exclusive right to make, use, and sell certain medical products and to receive information and assistance from Mr. Rasmusson to make, use and sell the products. Mr. Rasmusson is to receive royalties in the amount of 4% of the "net sales price" (as defined) of all licensed products sold. Royalties continue for the life of the product. If at any time a product covered by the agreement is no longer sold by the Company (defined as a reduction by 50% in sales from the previous calendar year), the license will no longer be exclusive as to that product. The agreement contains a provision for increasing the royalty amount if royalty rates paid by the Company to others for similar products are higher than 4%. The agreement also provides that upon the termination of the employments of a former officer, the royalty will be increased from 4% to 6% on certain products, and Mr. Rasmusson and the former officer will each receive royalties of 3% on sales of such products. During fiscal year 1999, 1998 and 1997, Mr. Rasmusson earned $40,881, $37,559 and 32,454, respectively, in royalties under this agreement.
The Company has been notified by Mr. Rasmusson that it is currently in default of royalty agreements related to certain medical products. Mr. Rasmusson has taken the position that the rights to these medical products have reverted back to him. The company believes that it is not in default. If Mr. Rasmmusson were to initiate a legal action to terminate such agreements, the Company would aggressively defend itself in such action and would challenge the validity of such agreements. In that event and if necessary and appropriate, the Company will seek to terminate the agreements or have them declared invalid or both. If, however, the royalty agreements are found valid and any resulting litigation is determined adversely to it, the Company may lose the right to manufacture and distribute products related to the royalty agreements. There could be a substantial negative impact on the Company's revenues and profits in such event until it located and acquired or developed alternative products.
Oxboro Outdoors, Inc. ("Oxboro Outdoors") entered into an exclusive license and royalty agreement with Mr. Rasmusson pursuant to which Mr. Rasmusson, as licensor, granted Oxboro Outdoors, as licensee, the exclusive right to make, use, and sell certain outdoor recreational products and to receive information and assistance from Mr. Rasmusson to make, use and sell the products. Pursuant to the terms of the royalty Agreement, advance royalties of $229,241 were paid by the Company to Mr. Rasmusson and as of June 30, 1999, royalties of $182,201 had been credited against advances paid to Mr. Rasmusson for products sold. The Company's payment obligations terminated with the sale of Oxboro Outdoors on June 30, 1999.
Consulting Agreements. During fiscal year 1996, the Company entered into a consulting agreement with Mr. Rasmusson whereby he would be paid an annual consulting fee of $150,000 for a period of five years commencing upon his retirement. Effective September 1, 1998, the Company and Mr. Rasmusson amended the consulting agreement, as part of the Mutual Release & Noncompetition Agreement, to reduce the term of the consulting agreement to 24 months, beginning September 1, 1998 and terminating August 31, 2000, and reduced the compensation payable under the consulting agreement to $485,000 payable in 24 equal monthly installments of $20,208.
Split Dollar Insurance. The Company adopted split dollar life insurance plans for the benefit of Mr. Rasmusson. Prior to September 1, 1998 and under the terms of Mr. Rasmusson's plan, the Company paid the annual premiums on two $500,000 insurance policies (the "Policies") on his life. The policies are whole life policies on which all premiums were paid by the Company and income is imputed to the insured in an amount equal to the term rate for his insurance as established by the insurer. The Policies are owned by Mr. Rasmusson. The plan was designed so that the Company will recover all premium payments, interest, and advances made by it on account of the Policies. The Company's interest in the premium payments, interest, and advances made with respect to the Policies are secured by a collateral assignment of the Policies. Upon the death of Mr. Rasmusson, the Company will be reimbursed from the insurance proceeds paid to the beneficiaries in an amount equal to the total premiums, interest, and advances made by the Company with respect to the Policies. In the event the Policies are surrendered for their cash surrender value at some date in the future, the Company will be reimbursed for the premiums it has paid on the Policies, plus interest. Premiums paid in fiscal 1999, 1998 and 1997 on behalf of Mr. Rasmusson totaled $47,095, $56,045 and $55,573, respectively. Effective September 1, 1998, pursuant to the terms of the Mutual Release & Noncompetition Agreement, the two Policies will be maintained by the Company so long as Mr. Rasmusson pays and maintains his portion of the monthly premiums on the Policies in a timely manner. If the Company fails to maintain payments or terminates either or both of the Policies or if the Policies cancel or terminate for any reason other than Mr. Ramusson's death, Mr. Rasmusson shall receive all of the cash value and/or termination value. Upon Mr. Rasmusson's death, the benefits under the Policies are to be paid out according to their terms.
See Compensation of Directors in this Proxy Statement for a description of the Company's consulting relationship with nominee director Gervaise Wilhelm.
Exercise of Stock Options
The Company was notified by the Nasdaq Stock Market in May 1999 that it failed to meet the minimum net tangible asset requirement for continued listing on the Nasdaq SmallCap Stock Market. The Company proposed a compliance plan to Nasdaq that included a rights offering to its shareholders of record at August 20, 1999. For each share held, shareholders received the right to purchase two shares of Common Stock and one immediately exercisable warrant for purchase of Common Stock of the Company for a purchase price of $2.50 per right. In connection with the compliance plan proposed by the Company and the rights offering, directors Kenneth W. Brimmer and Gary W. Copperud agreed to exercise individual options and to purchase sufficient rights to ensure that the Company would meet the Nasdaq net tangible asset requirement following the rights offering. Pursuant to this commitment, Messrs. Brimmer and Copperud each exercised options to purchase 4,000 shares of Common Stock of the Company at an exercise price of $5.00 per share for a purchase price of $20,000 each on exercise of their respective options.
Effective January 15, 1998, John R. Walter, a now former director of the Company, exercised options to purchase 40,000 (8,000 post-split) shares of the Company's Common Stock for an aggregate purchase price of $43,200. Mr. Walter paid the exercise price by delivery of a nonrecourse promissory note that provided for payment of the principal in five equal installment, commencing in January 1999, together with all interest accrued and unpaid as of the date of payment, and interest at an annual rate of 6%. The shares purchased were pledged as security for the note. In January 1999, Mr. Walter entered into an agreement with the Company whereby he returned 29,000 (5,800 post-split) shares to the Company in consideration of the cancellation of the promissory note and all accrued interest.
Nasdaq Compliance and Sale of Oxboro Outdoors, Inc.
During fiscal year 1999, the Company received notification from Nasdaq that it had failed to meet the minimum net tangible asset and market capitalization requirements for continued listing on the Nasdaq SmallCap Market. The Company implemented a plan of compliance that included a 1-for-5 reverse stock split, a rights offering to its shareholders of record at August 20, 1999 and the sale of Oxboro Outdoors, Inc., the Company's wholly-owned subsidiary. On August 13, 1999, the Company effected the reverse stock split to shareholders of record on that date. On June 30, 1999, the Company sold Oxboro Outdoors, Inc. for $385,000 in cash, a 9% promissory note of $265,000, subject to certain adjustments, and the assumption of liabilities of approximately $87,000. The Company received a $175,000 payment on the note in October 1999, with the remaining balance of $70,000 plus interest due paid on December 31, 1999. Effective September 1, 1999, the Company conducted a rights offering among its shareholders for the sale of 888,590 shares of Common Stock and 444,295 Warrants for purchase of Common Stock of the Company. The rights offering resulted in gross proceeds of approximately $1,110,737, an amount sufficient to meet the Nasdaq net tangible asset requirement. By letter dated October 19, 1999, Nasdaq notified the Company that it had demonstrated compliance with the Nasdaq net tangible asset and market capitalization requirements for continued listing on the SmallCap Market.
Compliance with Section 16(a) of the Securities Exchange Act of 1934
Section 16(a) of the Securities Exchange Act of 1934 requires the Company's directors and executive officers, and persons who own more than 10% of a registered class of the Company's equity securities, to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of Common Stock and other equity securities of the Company. These insiders are required by Securities and Exchange Commission regulations to furnish the Company with copies of all Section 16(a) forms they file, including Forms 3, 4 and 5. To the Company's knowledge, during the fiscal year ended September 30, 1999 all reports required by insiders were filed in a timely manner.
PROPOSAL 2:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION
TO CHANGE NAME
General
The shareholders are being asked to adopt Article I of the Company's Articles of Incorporation, as amended (the "Articles") to change the name of the Company to "Oxboro Medical, Inc." The resolution proposed for adoption by the shareholders and the full text of the proposed amendment are as set forth below.
Purpose and Effect of Amendment
The proposed amendment will effect a change of the Company's name to "Oxboro Medical, Inc." The Board of Directors believes this proposed name change is more conducive to the business of the Company.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the full text of Article I of the Company's Articles, as amended, are set forth as Proposal 2 on Exhibit A to this proxy statement.
Vote Required
The affirmative vote of a majority of the outstanding voting shares of the Company, together with the affirmative vote of a majority of the required quorum, is required for approval of this amendment to the Company's Articles at the 2000 Annual Meeting.
Recommendation of the Board of Directors
The Board of Directors believes that the amendment is necessary to better reflect the Company's business. The Board of Directors recommends that the shareholders vote FOR the approval of the foregoing amendment to the Company's Articles, identified as Proposal 2, at the 2000 Annual Meeting.
PROPOSAL 3:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION
TO INCREASE AUTHORIZED STOCK
General
The shareholders are being asked to amend Article VII of the Company's Articles to increase the authorized number of shares of the Company to 25,000,000 shares, to designate 20,000,000 of those shares as Common Stock, and to leave 5,000,000 shares undesignated. The Articles currently provide that the Company is authorized to issue 2,000,000 shares, all of which are designated as Common Stock. On February , 2000, 1,338,102 shares of Common Stock were issued and outstanding, 16,784 shares were reserved for issuance pursuant to the Company's recently terminated Employee Stock Ownership Plan and 50,400 shares of Common Stock were reserved for issuance upon the exercise of outstanding options. Subject to shareholder approval, it is anticipated that an additional 150,000 shares will be reserved for issuance upon adoption of the Company's 2000 Stock Option Plan. The remaining shares of authorized but unissued Common Stock are not reserved for any specific use and are available for future issuance.
Purpose and Effect of Amendment
The proposed amendment will provide authorized but unissued shares to replace those issued by the Company in its September 1999 rights offering. It will also provide the Company with the flexibility to make future issuances as necessary in connection with acquisitions or other corporate transactions that may be considered, to designate additional shares of Common Stock, or one or more classes of preferred stock, from time to time, and to issue shares from time to time in connection with the Company's current stock option plan and proposed 2000 Stock Option Plan (as described in this proxy statement). The proposed amendment to the Articles, authorizing an additional 20,000,000 shares of Common Stock and 5,000,000 undesignated shares, will provide the Company with the flexibility to accomplish these goals and other business and financial objectives in the future by avoiding any potential delay of its activities for further shareholder approval, except as may be required in particular cases by the Company's Articles or Bylaws, applicable law or the rules of any stock exchange or other system on which the Company's securities may then be listed. Future issuances of additional shares of Common Stock or securities convertible into Common Stock, whether pursuant to an acquisition or other corporate transaction, would have the effect of diluting shareholder voting rights and could have the effect of diluting earnings per share and book value per share of current shareholders. The availability for issuance of additional shares of Common Stock may also discourage or make more difficult efforts to obtain control of the Company.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the full text of Article VII of the Company's Articles, as amended, are set forth as Proposal 3 on Exhibit A to this proxy statement.
Vote Required
The affirmative vote of a majority of the outstanding voting shares of the Company, together with the affirmative vote of a majority of the required quorum, is required for approval of this amendment to the Company's Articles at the 2000 Annual Meeting.
Recommendation of the Board of Directors
The Board of Directors believes that the amendment is necessary to provide the Company with a sufficient number of shares for future issuances and the flexibility to take certain actions in the future. The Board of Directors recommends that the shareholders vote FOR the approval of the foregoing amendment to the Company's Articles, identified as Proposal 3, at the 2000 Annual Meeting.
PROPOSAL 4:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION
TO REDUCE SUPERMAJORITY VOTING PROVISIONS
General
The shareholders are being asked to amend Article IX of the Company's Articles, relating to the Board of Directors, to reduce from 75% to 662/3% the number of affirmative votes required by shareholders for passage of certain corporate actions. Article IX of the Company's Articles requires the approval of at least 75% of the voting power of the shares outstanding and entitled to vote in order to: (i) change the number of directors of the Company, (ii) remove a director from office, and (iii) amend or repeal provisions in or adopt provisions inconsistent with Article IX (the "supermajority voting provisions").
Purpose and Effect of Amendment
In connection with a rights offering to its shareholders effective September 1, 1999, the Company either established state securities law exemptions or filed appropriate state notifications to conduct the offering in several states. The rights offering included shareholders of the Company who are residents of the State of California. On review of the Company's Articles, the California Department of Corporations objected to the supermajority voting provisions of Article IX as inconsistent with California's shareholder democracy standards. Before the Company would be permitted to proceed with its rights offering in California, the Department of Corporations required the Company to provide an assurance that its Board of Directors would unanimously adopt and recommend for shareholder approval at the next annual meeting a proposal to reduce or eliminate the supermajority voting provisions present under Article IX. The Department of Corporations stated that it objected to any supermajority voting requirements that exceeded 662/3% of the outstanding shares entitled to vote and therefore required that this amendment be presented for approval.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the full text of Article IX of the Company's Articles, as amended, are set forth as Proposal 4 on Exhibit A to this proxy statement.
Vote Required
Pursuant to Article IX of the Company's Articles, amendment of Article IX requires the affirmative vote of either a majority of all of the shares entitled to vote or 75% of the voting shares present and entitled to vote at a meeting, together with the affirmative vote of a majority of the required quorum, for approval at the Company's 2000 Annual Meeting.
Recommendation of the Board of Directors
The Board of Directors believes that the amendment is necessary to permit shareholders of the Company the flexibility to approve corporate actions without the restrictions of supermajority voting requirements. The Board of Directors unanimously recommends that the shareholders vote FOR the approval of the foregoing amendment to the Company's Articles, identified as Proposal 4, at the 2000 Annual Meeting.
PROPOSAL 5:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION
TO WITHDRAW FROM PROVISIONS OF THE
MINNESOTA BUSINESS COMBINATIONS STATUTE
General
The shareholders are being asked to amend Article XII of the Company's Articles of Incorporation by eliminating Article XII so that the Company will no longer be subject to the Minnesota Business Combinations Statute, Section 302A.673 of the Minnesota Statutes.
Purpose and Effect of Amendment
Article XII of the Company's Articles states, in its entirety: "The corporation shall be subject to and governed by section 302A.673 of the Minnesota Statutes, as currently in effect and as may be amended from time to time." The amendment to Article XII is also being offered in accordance with the demands of the California Department of Corporations relating to the Company's rights offering in September 1999. The Department of Corporations advised the Company that all shareholders, including "interested shareholders" must be entitled to vote on matters subject to approval by holders of that class of shares. An "interested shareholder," with reference to an issuing public corporation, is generally defined in the Minnesota Statutes as a person who is:
"(1) the beneficial owner, directly or indirectly, of ten percent or more of the voting power of the outstanding shares entitled to vote of the issuing public corporation, or (2) an affiliate or associate of the issuing corporation and at any time within the four-year period immediately before the date in question was the beneficial owner, directly or indirectly, of ten percent or more of the voting power of the then outstanding shares entitled to vote of the issuing public corporation."
The Department of Corporations advised the Company that anti-takeover laws, including those reflected in the Company's Articles, fail to meet the Department's shareholder democracy standards because they prohibited interested shareholders from voting upon certain matters that may come before the Company's shareholders. In order for the Company to proceed with its rights offering in California, the Department of Corporations required that the Company's entire Board of Directors adopt and recommend for shareholder approval a proposal electing not to be subject to this Statute. The elimination of the protections of the Business Combinations Statute means that any shareholder, including interested shareholders, will be entitled to vote upon matters affecting the Company even though such votes may result in the sale or discontinuation of the Company. Please refer to the stock ownership table at page 2 of this proxy statement for information concerning shareholders who may be deemed to be interested shareholders. Pursuant to the Minnesota Statutes and subject to shareholder approval of the proposed amendment, effective 18 months from the date of such approval, the Company's Articles will be amended by the deletion of Article XII relating to the Minnesota Business Combinations Statute.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the full text of the current Article XII of the Company's Articles are set forth as Proposal 5 on Exhibit A to this proxy statement.
Vote Required
The affirmative vote of a majority of the outstanding voting shares of the Company, exclusive of any interested shareholders and their affiliates, together with the affirmative vote of a majority of the required quorum, is required for approval of this amendment to the Company's Articles at the Company's 2000 Annual Meeting, provided that the amendment will not become effective until 18 months after shareholder approval of the amendment.
Recommendation of the Board of Directors
The Board of Directors believes that the amendment is necessary to permit shareholders of the Company the flexibility to consider and approve certain corporate actions, and to permit interested shareholders to have fair participation in such actions, without the restrictions of the Minnesota Business Combinations Statute. The Board of Directors unanimously recommends that the shareholders vote FOR the approval of the foregoing amendment to the Company's Articles, identified as Proposal 5, at the 2000 Annual Meeting.
PROPOSAL 6:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION
TO WITHDRAW FROM PROVISIONS OF THE
MINNESOTA CONTROL SHARE ACQUISITION STATUTE
General
The shareholders are being asked to amend the Company's Articles of Incorporation by the addition of a provision stating that the Company will no longer be subject to the provisions of the Minnesota Control Share Acquisition Statute, Section 302A.671 of the Minnesota Statutes.
Purpose and Effect of Amendment
The Minnesota Control Share Acquisition Statute, Section 302A.671 of the Minnesota Statutes, (the "Control Share Act") is an anti-takeover measure that limits the acquisition of substantial voting power in an issuing public corporation. An "issuing public corporation" is defined as a publicly held corporation having at least 50 shareholders, any other corporation that has at least 100 shareholders, or any corporation having at least 50 shareholders that elects to be subject to the provisions of the Control Share Act. The Act applies only to "control share acquisitions." There are several important exceptions to the Control Share Act. For example, an acquisition of shares directly from the issuer does not constitute a control share acquisition. However, in general, a control share acquisition means an acquisition, directly or indirectly, by a 'person' (including a group of persons), of beneficial ownership of shares of an issuing public corporation so that immediately after the acquisition, the acquiring person can exercise or direct the exercise of a new range of voting power. The acquisition of a new range is described as follows:
If the number of shares acquired exceeds any of the above ranges, the acquiring person may vote, in the aggregate, only the threshold number of shares held (20%, 331/2% or 50%). The Control Share Act requires special shareholder approval in order for the acquiring person's shares to have the same voting rights as other shares of the same class or series. A resolution consenting to those rights must be approved by a majority of the shareholders of the issuing public corporation, excluding the acquiring person. The acquiring person must also provide the issuing public corporation with financial information and an information statement concerning any plans regarding the corporation in order to obtain this approval.
The Company reviewed the Control Share Act in connection with the rights offering extended to its shareholders who are residents of the State of California and the position of the California Department of Corporations that anti-takeover laws fail to meet the Department's shareholder democracy standards because they prohibit interested shareholders from voting upon certain matters that may come before the Company's shareholders. After review, the Board of Directors has determined that the Act is not in the best interests of all of the shareholders of the Company and may limit future opportunities for the Company. The elimination of the protections of the Control Share Act means that any shareholder, including shareholders who acquire more than 20% of the voting power of the Company, will be entitled to vote upon all matters affecting the Company, including votes may result in the sale or discontinuation of the Company. Please refer to the stock ownership table at page 2 of this proxy statement for information concerning shareholders who, because of the percentage of shares of the Company they beneficially own, may be subject to the Control Share Act.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the text of the new Article XIV of the Company's Articles are set forth as Proposal 6 on Exhibit A to this proxy statement.
Vote Required
The affirmative vote of the holders of a majority of the voting power of all shares of the Company entitled to vote, including all shares held by any acquiring person, and the affirmative vote of the holders of a majority of the voting power of all shares of the Company excluding any shares beneficially owned by any officer of the Company, together with the affirmative vote of a majority of the required quorum, is required for approval of this amendment to the Company's Articles at the Company's 2000 Annual Meeting.
Recommendation of the Board of Directors
The Board of Directors believes that the amendment is necessary to permit shareholders of the Company the flexibility to consider and approve certain corporate actions, and to permit interested shareholders to have fair participation in such actions, without the restrictions of the Minnesota Control Share Act. The Board of Directors unanimously recommends that the shareholders vote FOR the approval of the foregoing amendment to the Company's Articles, identified as Proposal 6, at the 2000 Annual Meeting.
PROPOSAL 7:
APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO
PERMIT WRITTEN ACTION OF DIRECTORS
BY LESS THAN UNANIMOUS CONSENT
General
The shareholders are being asked to amend the Company's Articles by the addition of a new Article XV, which will permit the directors of the Company to take action in writing by less than unanimous written consent in accordance with Section 302A.239 of the Minnesota Statutes. The amendment relates only to those actions which the Board of Directors is entitled to take in accordance with the Minnesota Statutes and does not limit or otherwise alter the authority of the shareholders to authorize or approve actions on behalf of the Company.
Purpose and Effect of Amendment
The Minnesota Statutes permit directors of a company to take action by written consent and to adopt resolutions by less than unanimous written consent provided (i) the action does not require shareholder approval and (ii) the action is signed by the number of directors that would be required to take the same action at a meeting of the Board of Directors at which all directors were present.
Amendment to Articles
The resolution proposed for adoption by the shareholders relating to this amendment and the full text of new Article XV of the Company's Articles are set forth as Proposal 7 on Exhibit A to this proxy statement.
Shareholder Approval
The affirmative vote of a majority of the outstanding voting shares of the Company, together with the affirmative vote of a majority of the required quorum, is required for approval of this amendment to the Company's Articles at the Company's 2000 Annual Meeting.
Recommendation of the Board of Directors
The Board of Directors believes that each of the foregoing amendments is necessary to provide the Company with the flexibility and efficiency to take certain actions and to effectively operate in the future. The Board of Directors recommends that the shareholders vote FOR the approval of each of the foregoing amendments to the Company's Articles, as included in Proposal 7, at the 2000 Annual Meeting.
PROPOSAL 8:
ADOPTION OF THE OXBORO MEDICAL INTERNATIONAL, INC.
2000 STOCK OPTION PLAN
General
The Board of Directors adopted the Oxboro Medical International, Inc. 2000 Stock Option Plan (the "Plan") on January 3, 2000, subject to shareholder approval. The following is a summary of the Plan. Please refer to Exhibit B attached to this Proxy Statement for the full text of the Plan.
Description of Plan
Purpose. The purpose of the Plan is to enable the Company and its subsidiaries to retain and attract executives, other key employees, members of the Board of Directors, and consultants who contribute to the Company's success by their ability, ingenuity and industry, and to enable these individuals to participate in the long-term success and growth of the Company by giving them a proprietary interest in the Company.
Eligible Participants. Officers, other key employees of the Company and its subsidiaries, members of the Board of Directors and consultants who are responsible for or contribute to the management, growth and/or profitability of the business of the Company and its subsidiaries are eligible to be granted stock options under the Plan. The Company currently has approximately 45 employees and four non-employee directors.
Administration. The Plan will be administered either by the Board of Directors or a committee appointed by the Board having at least two directors, all of whom will be non-employee directors within the meaning of Rule 16b-3 under the Securities Exchange Act of 1934 and outside directors within the meaning of Section 162(m) of the Internal Revenue Code of 1986, as amended (the "Code"). The Plan vests broad powers in the Committee to administer and interpret the Plan, including the authority to select the individuals to be granted awards and to prescribe the type, form and conditions of the awards (which may vary among participants). The Board has appointed Kenneth W. Brimmer and Gary W. Copperud as Administrators of the Plan.
Maximum Number of Shares. The initial total number of shares to be reserved for distribution under the Plan is 150,000 shares of Common Stock of the Company. No person will receive grants of stock options under the Plan that exceed 100,000 shares during any fiscal year of the Company.
Stock Options. The Plan permits the granting of two types of options: (i) Incentive Stock Options, which are intended to qualify under Section 422 of the Code, and (ii) Non-Qualified Stock Options. No Incentive Stock Options may be granted under the Plan after January 3, 2010. The option price of an Incentive Stock Option may not be less than 100% of the fair market value of the Company's Common Stock on the date of grant. If an employee owns more than 10% of the Combined voting power of the Company's outstanding voting stock, the option price shall be no less than 110% of the fair market value of the Company's Common Stock on the date of grant. The closing price of the Company's Common Stock on the Nasdaq SmallCap Market on January 3, 2000 was $3.50.
Exercise. Each option will become exercisable at such time and on such conditions as may be determined by the Committee. Upon exercise of an option under the Plan, the exercise price is to be paid by check, by other forms of consideration deemed sufficient by the Board of Committee, or by surrender of previously acquired shares of Common Stock of the Company which, in the case of stock acquired upon exercise of an option, have been owned for more than six months on the date of surrender, valued at its then fair market value. In the case of an Incentive Stock Option, the right to make a payment in the form of already owned shares may be authorized only at the time the option is granted. The aggregate fair market value (determined as of the time the stock option is granted) of the Common Stock with respect to which an Incentive Stock Option under the Plan is exercisable for the first time by an optionee during any calendar year shall not exceed $100,000.
Term; Transfer. The term of each option is established by the Committee, but shall not exceed 10 years (five years in the event of an optionee who owns more than 10% of the combined voting power of the Company's outstanding voting stock). Each option granted under the Plan is nontransferable during the lifetime of the optionee.
Other Conditions. The Committee may impose additional or alternative conditions and restrictions on the incentive or nonqualified stock options granted under the Plan; however, each incentive stock option must contain such limitations and restrictions upon its exercise as are necessary to ensure that the option will be an incentive stock option as defined in the Code.
Amendment. The Board of Directors may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation is permitted which (a) would impair the rights of an optionee or participant under a previously granted stock option award, without the optionee's or participant's consent, (b) without the approval of the shareholders of the Company, would cause the Plan no longer to comply with Rule 16b-3 under the Securities Exchange Act of 1934, Section 422 of the Code, or any other regulatory requirements, or (c) without the approval of the shareholders of the Company, would result in a repricing of any award or option previously granted under the Plan.
Federal Income Tax Consequences of the Plan
An optionee will not realize taxable income upon either the granting or exercise of an Incentive Stock Option. In addition, an optionee generally will not realize taxable compensation income upon the exercise of an incentive stock option if he or she exercises it as an employee or within three months after termination of employment (or within one year after termination if the termination results from a permanent or total disability). However, upon exercise of the Incentive Stock Option, the amount by which the fair market value of any shares exercised exceeds the option price is an item of tax preference for purposes of the alternative minimum tax. Upon the sale of such stock, the optionee generally will recognize capital gain or loss provided the stock has been held for at least two years from the date of the option grant and at least one year after the stock was purchased. Such capital gain or loss will be treated as long-term capital gain or loss and taxed at a maximum rate of 20% if the stock was held for at least 18 months, and will be treated as mid-term capital gain or loss and taxed at a maximum rate of 28% if the stock was held for more than 12 months but less than 18 months. If the applicable holding periods are not satisfied, then any gain realized in connection with the disposition of such stock will generally be taxable as ordinary compensation income in the year in which the disposition occurred, to the extent of the difference between the fair market value of such stock on the date of exercise and the option exercise price. The balance of any gain will be characterized as capital gain. The Company is entitled to a tax deduction to the extent, and at the time, that the participant realizes compensation income.
An optionee also will not realize taxable compensation income upon the grant of a Non-Qualified Stock Option. When an optionee exercises a Non-Qualified Stock Option, he or she realizes taxable compensation income at that time equal to the difference between the aggregate option price and the fair market value of the stock on the date of exercise. Upon the disposal of stock acquired pursuant to the Non-Qualified Option, the optionee's basis for determining taxable gain or loss will be the sum of the option price paid for the stock plus any related compensation income recognized by the optionee, and such gain or loss will be long-term or short-term capital gain or loss depending upon whether the optionee has held the shares for more than one year.
Vote Required
The affirmative vote of a majority of the shares represented at the annual meeting is required for approval of the Plan.
Recommendation of the Board of Directors
The Board of Directors recommends a vote FOR approval of the Company's 2000 Stock Option Plan presented as Proposal 8 at the Company's 2000 Annual Meeting.
Shareholder Proposals For 2001 Annual Meeting
Any shareholder proposal intended for inclusion in the Company's proxy material for the 2001 Annual Meeting of Shareholders must be received by the Secretary of the Company no later than the close of business on September 27, 2000.
A shareholder who wishes to make a proposal for consideration at the 2001 Annual Meeting, but does not seek to include the proposal in the Company's proxy material, must notify the Secretary of the Company. The notice must be received no later than December 11, 2000. If the notice is not received by that date, then the persons named on the Company's proxy card for the 2001 Annual Meeting may use their discretionary voting authority when the proposal is raised at the meeting.
Under the Company's Articles of Incorporation, as amended, for business to be properly brought before the 2001 Annual Meeting, a shareholder must give notice in writing to the Secretary of the Company no later than 50 days prior to the date of the meeting. Any proposal not submitted by that date will not be considered at the 2001 Annual Meeting.
Annual Report
The Annual Report of the Company for the fiscal year ended September 30, 1999 accompanies this Notice of Annual Meeting and Proxy Statement. Shareholders may also request without charge a copy of the Company's Annual Report on Form 10-KSB for the fiscal year ended September 30, 1999 by writing to: Oxboro Medical International, Inc., 13828 Lincoln Street N.E., Ham Lake, Minnesota 55304, Attention: Matthew E. Bellin, President, or by calling the Company at (612) 755-9516.
Relationship with Independent Accountants
Grant Thornton LLP has served as the Company's principal independent accountants to audit the Company's financial statements for the last five fiscal years. Representatives of Grant Thornton LLP are expected to be present at the Annual Meeting and will have the opportunity to make a statement, if they desire to do so, and to respond to appropriate questions.
Cost and Method of Solicitation
The Company will pay the cost of soliciting proxies and may make arrangements with brokerage firms, custodians, nominees and other fiduciaries to send proxy materials to beneficial owners of the Company's Common Stock. The Company will reimburse these parties for their reasonable out-of-pocket expenses incurred in connection with soliciting proxies on behalf of the Company. In addition to solicitation by mail, proxies may be solicited by telephone, electronic transmission or in person by directors, officers and employees of the Company.
Other Matters
As of the date of this Proxy Statement, management knows of no other matters that may come before the Annual Meeting. However, if matters other than those referred to above should properly come before the Annual Meeting, the individuals named on the enclosed proxy card intend to vote such proxy in accordance with their best judgment.
| February , 2000 |
|
|
By the Order of the Board of Directors |
| Matthew E. Bellin President and Chief Operating Officer |
EXHIBIT A
PROPOSED AMENDMENTS TO ARTICLES OF INCORPORATION
Proposal 2
Amendment to Change the Name of the Company
RESOLVED, That Article I of the Articles of Incorporation of the Company, as amended, be and hereby is amended to read in its entirety as follows:
The name of this Corporation shall be Oxboro Medical, Inc."
Proposal 3
Amendment to Increase the Authorized Stock
RESOLVED, That Article VII of the Articles of Incorporation of the Company, as amended, be and hereby is amended to read in its entirety as follows:
"The aggregate number of shares which this corporation shall have the authority to issue is Twenty-Five Million (25,000,000) shares, which shall consist of Twenty Million (20,000,000) shares of Common Stock, having $.01 par value per share, and Five Million (5,000,000) undesignated shares, having $.01 par value per share. The Board of Directors is authorized to establish from the undesignated shares, by resolution adopted and filed in the manner provided by law, one or more classes or series and to set forth the designation of each such class or series and fix the relative rights and preferences of each such class or series, including, but not limited to, fixing the relative voting rights, if any, of each such class or series to the full extent permitted by law. The Board of Directors shall be authorized to issue shares of Common Stock to holders of Common Stock and to holders of any class or series of undesignated shares and to issue shares of any class or series of undesignated shares to holders of Common Stock and to holders of any class or series of undesignated shares, in any case, for any purpose.
All shares of Common Stock shall be equal in every respect. At all meetings of the shareholders, each shareholder of record entitled to vote thereat shall be entitled to one (1) vote for each share (and a fractional vote for and equal to each fractional share) of Common Stock standing in his name and entitled to vote at such meetings. Shareholders shall have no rights of cumulative voting. Shareholders shall not be entitled, as a matter of right, preemptive or otherwise, to subscribe or apply for a purchase or receive any part of any unissued stock or other securities of this corporation, or of any stock or other securities issued and thereafter acquired by this corporation."
Proposal 4
Amendment to Reduce Supermajority Voting Provisions
RESOLVED, That Article IX of the Articles of Incorporation of the Company, as amended, be and hereby is amended and restated in its entirety so that each of the three references to shareholder approval by "75% of the voting power" of the Company shall be deleted and replaced by "662/3% of the voting power" of the Company and that such Article IX, as so amended, shall read in its entirety as follows:
The business and affairs of this corporation shall be managed by or under the direction of a Board of Directors consisting of not less than two persons, who need not be shareholders. The number of directors may be increased by the shareholders or by a 2/3 vote of the entire Board of Directors or decreased by the shareholders to not less than three; provided, however, that any change in the number of directors on the Board of Directors (including, without limitation, changes at annual meetings of shareholders) shall be approved by the affirmative vote of not less than 662/3% of the voting power of this corporation's shares outstanding and entitled to vote, voting together as a single class, unless such change shall have been approved by a majority of the entire Board of Directors. If such change shall not have been so approved, the number of directors shall remain the same. For purposes of this Article IX, the shares of this corporation entitled to vote shall be those shares of this corporation's capital stock entitled to vote generally in the election of directors of this corporation.
The directors shall be divided into three classes, designated Class I, Class II, and Class III, except as otherwise provided pursuant to this Article IX. Each class shall consist, as nearly as may be possible, of one-third of the total number of directors constituting the entire Board of Directors. At the 1990 annual meeting of shareholders, two directors shall be elected, one of whom shall be a Class I director elected for a one-year term and one of whom shall be a Class III director elected for a three-year term. Any Class II director elected by the shareholders or appointed by the Board of Directors prior to the 1992 annual meeting of shareholders shall serve until the 1992 annual meeting of shareholders. At each succeeding annual meeting of shareholders beginning in 1991, successors to the class of directors whose term expires at that annual meeting shall be elected for a three-year term. If the number of directors is changed, any increase or decrease shall be apportioned among the classes so as to maintain the number of directors in each class as nearly equal as possible, and any additional director of any class elected or appointed to fill a vacancy resulting from an increase in such class shall hold office resulting from an increase in such class shall hold office initially for a term that shall coincide with the remaining term of that class. In no case will a decrease in the number of directors shorten the term of any incumbent director. A director shall hold office until the annual meeting for the year in which the director's term expires and until a successor shall be elected and qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office. Removal of a director from office by the shareholders, with or without cause, shall require the affirmative vote of the greater of (1) a majority of the voting power of this corporation's shares outstanding and entitled to vote, voting together as a single class, or (2) at least 662/3% of the voting power of this corporation's shares present and entitled to vote, voting as a single class. Any vacancy on the Board of Directors that results from an increase in the number of directors shall be filled by a majority of the entire Board of Directors then in office, and any other vacancy occurring in the Board of Directors shall be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. Any director elected or appointed to fill a vacancy not resulting from an increase in the number of directors shall have the same remaining term as such director's predecessor. In addition to the authority of the shareholders to remove directors as described above, any director appointed by the Board of Directors to fill a vacancy, however created, may be removed prior to such director's initial election by the shareholders, with or without cause, by the vote of a majority of the other members of the Board of Directors then in office.
Notwithstanding the foregoing, whenever the holders of any one or more classes of capital stock (other than common stock) issued by this corporation shall have the right, voting separately by class or series, to elect directors at an annual or special meeting of shareholders, the election, term of office, filling of vacancies and other features of such directorships shall be governed by or pursuant to the applicable terms of the certificate of designation or other instrument creating such class or series of capital stock, and such directors so elected shall not be divided into classes pursuant to this Article IX unless expressly provided by such terms.
Only persons who are nominated in accordance with the procedures set forth in this Article IX shall be eligible for election as Directors. Nominations of persons for election to the Board of Directors. Nominations of persons for election to the Board of Directors of this corporation may be made at a meeting of shareholders (a) by or at the direction of the Board of Directors or (b) by any shareholder of this corporation entitled to vote for the election of Directors at the meeting who complies with the notice procedures set forth in this Article IX. Nominations by shareholders shall be made pursuant to timely notice in writing to the Secretary of this corporation. To be timely, a shareholder's notice shall be delivered to or mailed and received at the principal executive offices of this corporation not less than 50 days prior to the meeting; provided, however, that in the event that less than 60 days' notice or prior public disclosure of the date of the meeting is given or made to shareholders, notice by the shareholder to be timely must be so received not later than the close of business on the 10th day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made. Such shareholder's notice shall set forth (a) as to each person whom the shareholder proposes to nominate for election or re-election as a director, all information relating to such person that is required (or would be required if this corporation were subject to Regulation 14A under the Securities Exchange Act of 1934, as amended) to be disclosed in solicitations of proxies or otherwise pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (including such person's written consent to being named in the proxy statement as a nominee and to serving as a director if elected); and (b) as to the shareholder giving the notice (i) the name and address, as they appear on the corporation's books, of such shareholder and (ii) the class and number of shares of this corporation which are beneficially owned by such shareholder. At the request of the Board of Directors any person nominated by the Board of Directors for election as a director shall furnish to the Secretary of this corporation that information required to be set forth in a shareholder's notice of nomination which pertains to the nominee. No person shall be eligible for election as a director of this corporation unless nominated in accordance with the procedures set forth in this Article IX. The Chairman of the meeting shall, if the facts warrant, determine that a nomination was not made in accordance with the procedures prescribed in this Article IX and, if he should so determine, he shall so declare to the meeting and the defective nomination shall be disregarded.
At any regular or special meeting of the shareholders, only such business shall be conducted as shall have been brought before the meeting (a) by or at the direction of the Board of Directors or (b) by any shareholder of this corporation who complies with the notice procedures set forth in this Article IX. For business to be properly brought before any regular or special meeting by a shareholder, the shareholder must have given timely notice thereof in writing to the Secretary of this corporation. To be timely, a shareholder's notice must be delivered to or mailed and received at the principal executive offices of the corporation not less than 50 days prior to the meeting, provided, however, that in the event that less than 60 days' notice or prior public disclosure of the date of the meeting is given or made to the shareholders notice by the shareholder to be timely must be received not later than the close of business on the 10th day following the day on which such notice of the date of the regular or special meeting was mailed or such public disclosure was made. A shareholder's notice to the Secretary shall set forth as to each matter the shareholder proposes to bring before the regular or special meeting (a) a brief description of the business desired to be brought before the meting and the reasons for conducting such business at the meeting, (b) the name and address, as they appear on this corporation's books, of the shareholder proposing such business, (c) the class and number of shares of this corporation which are beneficially owned by the shareholder and (d) any material interest of the shareholder in such business. Notwithstanding anything in this corporation's Bylaws to the contrary, no business shall be conducted at any regular or special meeting except in accordance with the procedures set forth in this Article IX. The Chairman of the meeting shall, if the facts warrant, determine that business was not properly brought before the meeting in accordance with the provisions of this Article IX and, if he should so determine, he shall so declare to the meeting and any such business not properly brought before the meeting shall not be transacted.
Notwithstanding any other provisions of these Articles of Incorporation (and notwithstanding the fact that a lesser percentage or separate class vote may be specified by law or these Articles of Incorporation), the affirmative vote o the holders of the greater of (1) a majority of the voting power of this corporation's shares outstanding and entitled to vote or (2) at least 662/3% of the voting power of this corporation's shares present and entitled to vote, in each case voting together as a single class, shall be required to amend or repeal, or adopt any provisions inconsistent with, this Article IX."
Proposal 5
Amendment to Withdraw From Provisions of
the Minnesota Business Combinations Statute
RESOLVED, That pursuant to Section 302A.673, Subdivision 3(b)(3) of the Minnesota Statutes, the shareholders of the Company hereby expressly elect to no longer be subject to the Minnesota Business Combinations Statute, Section 302A.673 of the Minnesota Statutes;
FURTHER RESOLVED, That, except as provided in Section 302A.673, Subdivision 3(c) of the Minnesota Statutes, the adoption of these resolutions shall not apply to any business combinations of the Company with an interested shareholder whose share acquisition date is on or before the effective date of this resolution; and
FURTHER RESOLVED, That, effective 18 months from this date, Article XII of the Articles of Incorporation of the Company, as amended, be and hereby is amended to read in its entirety as follows:
The shareholders of this corporation expressly elect not to be subject to the provisions of the Minnesota Business Combination Statute, Section 302A.673 of the Minnesota Statutes as currently in effect and as may be amended from time to time. This Article XII, as amended, shall become effective 18 months from the date of shareholder approval of this amendment on March , 2000, and except as otherwise provided in Section 302A.673, Subdivision 3(c) of the Minnesota Statutes, this election shall not apply to any business combination of the corporation with an interested shareholder whose share acquisition date is on or before the effective date of this amendment."
Proposal 6
Amendment to Elect Not to be Subject to the Provisions of the
Minnesota Control Share Acquisition Statute
RESOLVED, That, pursuant to Section 302A.671, Subdivision 1(a) and Subdivision 4a(b) of the Minnesota Statutes, the shareholders of the Company hereby expressly elect not to be subject to the Minnesota Control Share Acquisition Statute, Section 302A.671, et. seq., of the Minnesota Statutes;
FURTHER RESOLVED, That the Articles of Incorporation of the Company, as amended, are hereby amended by the addition of Article XIII, which shall read in its entirety as follows:
The shareholders of this corporation expressly elect not to be subject to the provisions of the Control Share Acquisition Statutes, Section 302A.671 of the Minnesota Statutes."
FURTHER RESOLVED, That upon the effective date of filing of this amendment, the existing Article XIII in the Articles of Incorporation shall be renumbered as Article XIV and replaced by the foregoing amendment.
Proposal 7
Amendment to Permit Written Action of the Board of Directors
by Less Than Unanimous Consent
RESOLVED, That the Articles of Incorporation of the Company, as amended, be and hereby are amended by the addition of Article XV, which shall read in its entirety as follows:
In accordance with Section 302A.239, Subdivision 1 of the Minnesota Statutes, any actions taken by written consent of the Board of Directors of this corporation, other than an action requiring shareholder approval, shall be effective if signed either by all of the directors or by the number of directors that would be required to take the same action at a meeting of the Board at which all directors were present."
OXBORO MEDICAL INTERNATIONAL, INC.
2000 STOCK OPTION PLAN
| |
|
Page |
||
|---|---|---|---|---|
| SECTION 1. | General Purpose of Plan; Definitions | B-1 | ||
| SECTION 2. | Administration | B-2 | ||
| SECTION 3. | Stock Subject to Plan | B-3 | ||
| SECTION 4. | Eligibility | B-3 | ||
| SECTION 5. | Stock Options | B-4 | ||
| SECTION 6. | Transfer, Leave of Absence, Etc | B-6 | ||
| SECTION 7. | Amendments and Termination | B-7 | ||
| SECTION 8. | General Provisions | B-7 | ||
| SECTION 9. | Effective Date of Plan | B-8 |
OXBORO MEDICAL INTERNATIONAL, INC.
SECTION 1. General Purpose of Plan; Definitions.
The name of this plan is the Oxboro Medical International, Inc. 2000 Stock Option Plan (the "Plan"). The purpose of the Plan is to enable Oxboro Medical International, Inc. (the "Company") and its Subsidiaries to retain and attract executives, other key employees, members of the Board of Directors, and consultants who contribute to the Company's success by their ability, ingenuity and industry, and to enable such individuals to participate in the long-term success and growth of the Company by giving them a proprietary interest in the Company.
For purposes of the Plan, the following terms shall be defined as set forth below:
SECTION 2. Administration.
The Plan shall be administered by the Board or by a Committee appointed by the Board which shall have such attributes as will be in compliance with the provisions of Rule 16b-3 of the Securities Exchange Act of 1934 and which and shall serve at the pleasure of the Board. Any or all of the functions of the Board specified in the Plan may be exercised by the Committee designated by the Board, unless the Plan specifically provides otherwise.
The Board shall have the power and authority to grant Stock Options to eligible optionees pursuant to the terms of the Plan. In particular, the Board shall have the authority:
The Board shall have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it shall, from time to time, deem advisable; to interpret the terms and provisions of the Plan and any award issued under the Plan (and any agreements relating thereto); and to otherwise supervise the administration of the Plan. The Board may delegate to executive officers of the Company the authority to exercise the powers specified in clauses (a), (b), (c) and (d) above with respect to persons who are not either the chief executive officer of the Company or the four highest paid officers of the Company other than the chief executive officer.
All decisions made by the Board pursuant to the provisions of the Plan shall be final and binding on all persons, including the Company and Plan participants.
SECTION 3. Stock Subject to Plan.
The total number of shares of Stock reserved and available for distribution under the Plan shall be 150,000. Such shares may consist, in whole or in part, of authorized and unissued shares.
If any shares that have been optioned cease to be subject to Stock Options, such shares shall again be available for distribution in connection with future awards under the Plan. Upon a stock-for-stock exercise of a Stock Option or upon the withholding of stock for the payment of the option price or taxes, only the net number of shares issued to the optionee shall be used to calculate the number of shares remaining available for distribution under the Plan.
In the event of any merger, reorganization, consolidation, recapitalization, stock dividend, stock split, other change in corporate structure affecting the Stock, or spin-off or other distribution of assets to stockholders, such substitution or adjustment shall be made in the aggregate number of shares reserved for issuance under the Plan, and in the number and option price of shares subject to outstanding options granted under the Plan. In the event such action results in the Company subdividing its outstanding Common Stock into a greater number of shares or declaring a dividend payable in Common Stock, the Stock Option exercise price in effect immediately prior to such subdivision will be proportionately reduced and the number of shares of Common Stock purchasable pursuant to such Stock Option will be proportionately increased. Conversely, in the event the Company's outstanding Common Stock is combined into a small number of shares, the Stock Option exercise price in effect immediately prior to such combination will be proportionately increased and the number of shares of Common Stock purchasable upon the exercise of such Stock Option will be proportionately reduced.
Upon each adjustment of the Stock Option exercise price as set forth above, the holder of the Stock Option will thereafter be entitled to purchase, at the option exercise price resulting from such adjustment, the number of shares of Common Stock obtained by multiplying the option exercise price in effect immediately prior to such adjustment by the number of shares of Common Stock purchasable immediately prior to such adjustment and dividing the product thereof by the option exercise price resulting from such adjustment. An adjustment made pursuant to this paragraph shall become effective immediately after the effective date of such event, retroactive to the record date, if any, for such event and provided that the number of shares subject to any award upon exercise of the option resulting from such adjustment shall always be a whole number.
SECTION 4. Eligibility.
Officers, other key employees of the Company and its Subsidiaries, members of the Board, and Consultants who are responsible for or contribute to the management, growth and/or profitability of the business of the Company and its Subsidiaries are eligible to be granted Stock Options under the Plan. The optionees and participants under the Plan shall be selected from time to time by the Board or the Committee, in its sole discretion, from among those eligible, and the Board or the Committee shall determine, in its sole discretion, the number of shares covered by each award.
Notwithstanding the foregoing, no person shall receive grants of Stock Options under this Plan that exceed 100,000 shares during any fiscal year of the Company.
SECTION 5. Stock Options.
Any Stock Option granted under the Plan shall be in such form as the Board or the Committee may from time to time approve. In addition, subject to the restrictions contained in this Plan and applicable law, the Board or the Committee shall have the authority to modify the terms and conditions of any previously granted Stock Option.
The Stock Options granted under the Plan may be of two types: (i) Incentive Stock Options and (ii) Non-Qualified Stock Options. No Incentive Stock Options shall be granted under the Plan after January 3, 2010.
The Board or its designated Committee shall have the authority to grant any optionee Incentive Stock Options, Non-Qualified Stock Options, or both types of options. To the extent that any option or portion of an option does not qualify as an Incentive Stock Option, it shall constitute a separate Non-Qualified Stock Option.
Anything in the Plan to the contrary notwithstanding, no term of the Plan relating to Incentive Stock Options shall be interpreted, amended or altered, nor shall any discretion or authority granted under the Plan be so exercised, so as to disqualify either the Plan or any Incentive Stock Option under Section 422 of the Code. The preceding sentence shall not preclude any modification or amendment to an outstanding Incentive Stock Option, whether or not such modification or amendment results in disqualification of such Stock Option as an Incentive Stock Option, provided the optionee consents in writing to the modification or amendment.
Stock Options granted under the Plan shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Board or its designated Committee shall deem desirable:
The grant of a Stock Option pursuant to the Plan shall not limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure or to merge, exchange or consolidate or to dissolve, liquidate or transfer all or any part of its business or assets.
SECTION 6. Transfer, Leave of Absence, Etc.
For purposes of the Plan, the following events shall not be deemed a termination of employment:
SECTION 7. Amendments and Termination.
The Board may amend, alter, or discontinue the Plan, but no amendment, alteration, or discontinuation shall be made (a) which would impair the rights of an optionee or participant under a Stock Option award theretofore granted, without the optionee's or participant's consent, (b) which, without the approval of the stockholders of the Company, would cause the Plan no longer to comply with Rule 16b-3 under the Securities Exchange Act of 1934, Section 422 of the Code, or any other regulatory requirements, or (c) without the approval of the stockholders of the Company, result in a repricing of any award or option theretofore granted hereunder.
The Board or the Committee may amend the terms of any award or Stock Option theretofore granted, prospectively or retroactively, to the extent such amendment is consistent with the terms of the Plan, but no such amendment shall impair the rights of any holder without his or her consent except to the extent authorized under the Plan. The Board or the Committee may also substitute new Stock Options for previously granted stock options, including previously granted stock options having higher exercise prices.
SECTION 8. General Provisions.
All certificates for shares of Stock delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Board or the Committee may deem advisable under the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Stock is then listed, and any applicable federal or state securities laws, and the Board or the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.
SECTION 9. Effective Date of Plan.
The Plan shall be effective on the date it is adopted by the Board of Directors.
Adopted by the Board of Directors on January 3, 2000.
Approved by the Shareholders on March , 2000.
APPENDIX A
| 1. | Election of Directors | Gervaise Wilhelm | / / | FOR the nominee |
/ / | WITHHOLD AUTHORITY To vote for the nominee |
||||||||||||||
| 2. | Proposal to approve an amendment to the Articles of Incorporation of the Company to change the name of the Company to "Oxboro Medical, Inc." | / / | For | / / | Against | / / | Abstain | |||||||||||||
| 3. | Proposal to approve an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares to 25,000,000. | / / | For | / / | Against | / / | Abstain | |||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| — Please fold here — | ||||||||||||||||||||
| 4. | Proposal to approve an amendment to the Articles of Incorporation of the Company to eliminate supermajority voting provisions. | / / | For | / / | Against | / / | Abstain | |||||||
| 5. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Business Combinations Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 6. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Control Share Acquisitions Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 7. | Proposal to approve an amendment to the Articles of Incorporation of the Company to permit written action by less than all of the Board of Directors. | / / | For | / / | Against | / / | Abstain | |||||||
| 8. | Proposal to approve the 2000 Stock Option Plan of the Company. | / / | For | / / | Against | / / | Abstain | |||||||
| 9. |
|
In their discretion, on such other business as may properly come before the meeting or any adjournment thereof. |
|
|
|
|
|
|
|
|
|
|
|
|
THIS PROXY WHEN PROPERLY EXECUTED AND RETURNED WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THE PROXY WILL BE VOTED "FOR" PROPOSALS (1), (2), (3), (4), (5), (6), (7) and (8).
| Address change? Mark Box / / | Dated: | , 2000 | |||
| Indicate changes below: | |||||
| |
|
|
|||
| |
|
|
|||
| |
|
Signature(s) in Box |
|||
| |
|
Please vote, date and sign this proxy exactly as your name is printed hereon. When signing as attorney, executor, administrator, trustee, guardian, etc. give full title as such. If the stock is held jointly, each owner should sign. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person. |
|||
| OXBORO MEDICAL INTERNATIONAL, INC. |
||
| |
|
ANNUAL MEETING OF SHAREHOLDERS |
| |
|
Thursday, March , 2000 at 4:00 p.m. |
| |
|
Oxboro Medical International, Inc. 13828 Lincoln Street N.E. Ham Lake, MN 55304 |
| |
|
|
| [LOGO] | proxy | |||
The signatory of this card hereby appoints Kenneth W. Brimmer and Gary W. Copperud, or either of them, as Proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated below, all the shares of Common Stock of Oxboro Medical International, Inc. (the "Company") held of record by the undersigned on January 18, 2000 and which the undersigned would be entitled to vote at the Annual Meeting of Shareholders to be held on March , 2000, or at any adjournment or adjournments thereof, hereby revoking all former proxies.
This Proxy is Solicited on Behalf of the Board of Directors.
If no choice is specified, the proxy will be voted "for" each proposal.
See reverse for voting instructions.
APPENDIX B
| 1. | Election of Directors | Gervaise Wilhelm | / / | FOR the nominee |
/ / | WITHHOLD AUTHORITY To vote for the nominee |
||||||||||||||
| 2. | Proposal to approve an amendment to the Articles of Incorporation of the Company to change the name of the Company to "Oxboro Medical, Inc." | / / | For | / / | Against | / / | Abstain | |||||||||||||
| 3. | Proposal to approve an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares to 25,000,000. | / / | For | / / | Against | / / | Abstain | |||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| — Please fold here — |
| 4. | Proposal to approve an amendment to the Articles of Incorporation of the Company to eliminate supermajority voting provisions. | / / | For | / / | Against | / / | Abstain | |||||||
| 5. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Business Combinations Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 6. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Control Share Acquisitions Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 7. | Proposal to approve an amendment to the Articles of Incorporation of the Company to permit written action by less than all of the Board of Directors. | / / | For | / / | Against | / / | Abstain | |||||||
| 8. | Proposal to approve the 2000 Stock Option Plan of the Company. | / / | For | / / | Against | / / | Abstain | |||||||
| 9. |
|
In their discretion, on such other business as may properly come before the meeting or any adjournment thereof. |
|
|
|
|
|
|
|
|
|
|
|
|
THIS PROXY WHEN PROPERLY EXECUTED AND RETURNED WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THE PROXY WILL BE VOTED "FOR" PROPOSALS (1), (2), (3), (4), (5), (6), (7) and (8).
| Address change? Mark Box / / | Dated: | , 2000 | |||
| Indicate changes below: | |||||
| |
|
|
|||
| |
|
|
|||
| |
|
Signature(s) in Box |
|||
| |
|
Please vote, date and sign this proxy exactly as your name is printed hereon. When signing as attorney, executor, administrator, trustee, guardian, etc. give full title as such. If the stock is held jointly, each owner should sign. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person. |
|||
| OXBORO MEDICAL INTERNATIONAL, INC. |
||
| |
|
ANNUAL MEETING OF SHAREHOLDERS |
| |
|
Thursday, March , 2000 at 4:00 p.m. |
| |
|
Oxboro Medical International, Inc. 13828 Lincoln Street N.E. Ham Lake, MN 55304 |
| |
|
|
| [LOGO] | proxy | |||
The signatory of this card hereby appoints Kenneth W. Brimmer and Gary W. Copperud, or either of them, as Proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated below, all the shares of Common Stock of Oxboro Medical International, Inc. (the "Company") held of record by the undersigned on January 18, 2000 and which the undersigned would be entitled to vote at the Annual Meeting of Shareholders to be held on March , 2000, or at any adjournment or adjournments thereof, hereby revoking all former proxies.
The Company's stock records indicate that you have not presented your stock certificate(s) for exchange following the 1-for-10 reverse stock split effected in April 1987. Giving effect to this reverse split, and to subsequent stock splits of 3-for-2 (January 1990) and 2-for-1 (March 1991) and reverse 1-for-5 (August 1999), each 10 shares listed on this proxy card as held of record by you will be entitled to 3 votes on all matters to be presented to the shareholders at the 2000 Annual Meeting.
This Proxy is Solicited on Behalf of the Board of Directors
If no choice is specified, the proxy will be voted "for" each proposal.
See reverse for voting instructions.
APPENDIX C
| 1. | Election of Directors | Gervaise Wilhelm | / / | FOR the nominee |
/ / | WITHHOLD AUTHORITY To vote for the nominee |
||||||||||||||
| 2. | Proposal to approve an amendment to the Articles of Incorporation of the Company to change the name of the Company to "Oxboro Medical, Inc." | / / | For | / / | Against | / / | Abstain | |||||||||||||
| 3. | Proposal to approve an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares to 25,000,000. | / / | For | / / | Against | / / | Abstain | |||||||||||||
| — Please fold here — |
| 4. | Proposal to approve an amendment to the Articles of Incorporation of the Company to eliminate supermajority voting provisions. | / / | For | / / | Against | / / | Abstain | |||||||
| 5. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Business Combinations Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 6. | Proposal to approve an amendment to the Articles of Incorporation of the Company to elect not to be subject to the provisions of the Minnesota Control Share Acquisitions Statute. | / / | For | / / | Against | / / | Abstain | |||||||
| 7. | Proposal to approve an amendment to the Articles of Incorporation of the Company to permit written action by less than all of the Board of Directors. | / / | For | / / | Against | / / | Abstain | |||||||
| 8. | Proposal to approve the 2000 Stock Option Plan of the Company. | / / | For | / / | Against | / / | Abstain | |||||||
| 9. |
|
In their discretion, on such other business as may properly come before the meeting or any adjournment thereof. |
|
|
|
|
|
|
|
|
|
|
|
|
THIS PROXY WHEN PROPERLY EXECUTED AND RETURNED WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THE PROXY WILL BE VOTED "FOR" PROPOSALS (1), (2), (3), (4), (5), (6), (7) and (8).
| Address change? Mark Box / / | Dated: | , 2000 | |||
| Indicate changes below: | |||||
| |
|
|
|||
| |
|
|
|||
| |
|
Signature(s) in Box |
|||
| |
|
Please vote, date and sign this proxy exactly as your name is printed hereon. When signing as attorney, executor, administrator, trustee, guardian, etc. give full title as such. If the stock is held jointly, each owner should sign. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person. |
|||
| OXBORO MEDICAL INTERNATIONAL, INC. |
||
| |
|
ANNUAL MEETING OF SHAREHOLDERS |
| |
|
Thursday, March , 2000 at 4:00 p.m. |
| |
|
Oxboro Medical International, Inc. 13828 Lincoln Street N.E. Ham Lake, MN 55304 |
| |
|
|
| [LOGO] | proxy | |||
The signatory of this card hereby appoints Kenneth W. Brimmer and Gary W. Copperud, or either of them, as Proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated below, all the shares of Common Stock of Oxboro Medical International, Inc. (the "Company") held of record by the undersigned on January 18, 2000 and which the undersigned would be entitled to vote at the Annual Meeting of Shareholders to be held on March , 2000, or at any adjournment or adjournments thereof, hereby revoking all former proxies.
The Company's stock records indicate that you have not presented your stock certificate(s) for exchange following the 1-for-10 reverse stock split effected in April 1987. Giving effect to this reverse split, and to subsequent stock splits of 3-for-2 (January 1990) and 2-for-1 (March 1991) and reverse 1-for-5 (August 1999), each 10 shares listed on this proxy card as held of record by you will be entitled to 3 votes on all matters to be presented to the shareholders at the 2000 Annual Meeting.
This Proxy is Solicited on Behalf of the Board of Directors
If no choice is specified, the proxy will be voted "for" each proposal.
See reverse for voting instructions.
GENERAL INFORMATION
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
PROPOSAL 1: ELECTION OF DIRECTORS
Summary Compensation Table
Certain Relationships and Related Transactions
PROPOSAL 2: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO CHANGE NAME
PROPOSAL 3: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO INCREASE AUTHORIZED STOCK
PROPOSAL 4: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO REDUCE SUPERMAJORITY VOTING PROVISIONS
PROPOSAL 5: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO WITHDRAW FROM PROVISIONS OF THE MINNESOTA BUSINESS COMBINATIONS STATUTE
PROPOSAL 6: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO WITHDRAW FROM PROVISIONS OF THE MINNESOTA CONTROL SHARE ACQUISITION STATUTE
PROPOSAL 7: APPROVAL OF AMENDMENT TO ARTICLES OF INCORPORATION TO PERMIT WRITTEN ACTION OF DIRECTORS BY LESS THAN UNANIMOUS CONSENT
PROPOSAL 8: ADOPTION OF THE OXBORO MEDICAL INTERNATIONAL, INC. 2000 STOCK OPTION PLAN
OTHER INFORMATION
EXHIBIT A PROPOSED AMENDMENTS TO ARTICLES OF INCORPORATION
Proposal 2 Amendment to Change the Name of the Company
"ARTICLE I
Proposal 3 Amendment to Increase the Authorized Stock
Proposal 4 Amendment to Reduce Supermajority Voting Provisions
"ARTICLE IX
Proposal 5 Amendment to Withdraw From Provisions of the Minnesota Business Combinations Statute
"Article XII
Proposal 6 Amendment to Elect Not to be Subject to the Provisions of the Minnesota Control Share Acquisition Statute
"Article XIII
Proposal 7 Amendment to Permit Written Action of the Board of Directors by Less Than Unanimous Consent
"ARTICLE XV
|
|